Who invested in Arkis BioSciences

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$4.2Mraised across 2 rounds since 2016, from 2 sources

$3.4MSeries A$795KRound

Latest round: Round, $795KFeb 2019
Biggest round: $3.4MSeries A · Jun 2016
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019

$3.4MSeries A$795KRound

First round: Series A, $3.4M
Biggest round: $3.4M
Between rounds: 2.6 years

The rounds

Feb 2019
Round$795K1 returning
- Innova Memphis
Source recorded
Jun 2016
Series A$3.4M1 new
- Innova Memphis
Reported by FinSMEsSEC filing: $2.3M sold, first sale Jun 2016

Founders and team

From the SEC filings it signed: 4 on the team.

Chad E. SeaverExecutive Officer, Directori
James A. KillefferExecutive Officer, Directori
Quentin A. AtenExecutive Officeri
Stephen A. ArnoldExecutive Officeri

On the board, as filediClif A. MoyersKen A. Woody

Everyone who backed them

Innova MemphisGovernment2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Arkis BioSciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.